Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Other Accumulated Expenses (2016 - 2025)

Prothena Corp Public has reported Other Accumulated Expenses over the past 14 years, most recently at $11.8 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $11.8 million for Q4 2025, down 25.61% from a year ago — trailing twelve months through Dec 2025 was $11.8 million (down 25.61% YoY), and the annual figure for FY2025 was $11.8 million, down 25.61%.
  • Other Accumulated Expenses for Q4 2025 was $11.8 million at Prothena Corp Public, up from $8.2 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for PRTA hit a ceiling of $15.8 million in Q4 2024 and a floor of $4.3 million in Q1 2021.
  • Median Other Accumulated Expenses over the past 5 years was $9.5 million (2021), compared with a mean of $10.0 million.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 78.73% in 2022 and later plummeted 42.61% in 2025.
  • Prothena Corp Public's Other Accumulated Expenses stood at $9.8 million in 2021, then grew by 24.0% to $12.2 million in 2022, then rose by 28.71% to $15.7 million in 2023, then grew by 1.16% to $15.8 million in 2024, then fell by 25.61% to $11.8 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $11.8 million (Q4 2025), $8.2 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.